Search Results

You are looking at 1 - 7 of 7 items for :

  • Advances and Future Directions in Pheochromocytoma and Paraganglioma x
  • Refine by access: All content x
Clear All
Paul Benjamin Loughrey Patrick G Johnston Centre for Cancer Research, Queen’s University, Belfast, UK
Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Paul Benjamin Loughrey in
Google Scholar
PubMed
Close
,
Federico Roncaroli Geoffrey Jefferson Brain Research Centre, Division of Neuroscience and Experimental Psychology, School of Medicine, Manchester University, Manchester, UK

Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
Close
,
Estelle Healy Department of Cellular Pathology, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Estelle Healy in
Google Scholar
PubMed
Close
,
Philip Weir Department of Neurosurgery, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Philip Weir in
Google Scholar
PubMed
Close
,
Madhu Basetti Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK

Search for other papers by Madhu Basetti in
Google Scholar
PubMed
Close
,
Ruth T Casey Department of Endocrinology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK

Search for other papers by Ruth T Casey in
Google Scholar
PubMed
Close
,
Steven J Hunter Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Steven J Hunter in
Google Scholar
PubMed
Close
, and
Márta Korbonits Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK

Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Close

coincidental. Succinate dehydrogenase (SDH) gene variants (collectively known as SDHx ) can associate with PPGL ( Baysal et al. 2000 ). The association of PitNET and PPGL in the setting of SDHx variant was established at the molecular level in 2012

Open access
Susan Richter Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany

Search for other papers by Susan Richter in
Google Scholar
PubMed
Close
,
Timothy J Garrett Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA

Search for other papers by Timothy J Garrett in
Google Scholar
PubMed
Close
,
Nicole Bechmann Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany

Search for other papers by Nicole Bechmann in
Google Scholar
PubMed
Close
,
Roderick J Clifton-Bligh Cancer Genetics Laboratory, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, St Leonards, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, Australia

Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
Close
, and
Hans K Ghayee Department of Internal Medicine, Division of Endocrinology, University of Florida College of Medicine and Malcom Randall VA Medical Center, Gainesville, Florida, USA

Search for other papers by Hans K Ghayee in
Google Scholar
PubMed
Close

identify the underlying cause, and patients who have a confirmed mutation in an SDHx gene but no PPGL yet should undergo regular follow-up ( Lenders et al. 2014 , Amar et al. 2021 ). Besides PPGL, SDHx PVs predispose to renal cell carcinomas

Open access
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed
Close
and
Roderick Clifton-Bligh Department of Endocrinology Royal North Shore Hospital, University of Sydney, Australia

Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed
Close

( Lenders et al. 2020 ); (c) 2021 International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers outlining the most important considerations and diagnostic steps in the assessment of SDHx carriers ( Amar et al. 2021

Free access
Anne-Paule Gimenez-Roqueplo Université Paris Cité, PARCC, INSERM, Paris, France
Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France

Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Close
,
Mercedes Robledo Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain

Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Close
, and
Patricia L M Dahia Division of Hematology and Medical Oncology, Department Medicine, University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas, USA
Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA

Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
Close

( Buffet et al. 2019 ). The study compared the management and outcome of 221 patients diagnosed with PGL carrying mutations in SDHx or VHL who were informed of their positive genetic status either within the first year or more than 7 years after the

Open access
David Taïeb Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France

Search for other papers by David Taïeb in
Google Scholar
PubMed
Close
,
Christelle Fargette Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France

Search for other papers by Christelle Fargette in
Google Scholar
PubMed
Close
,
Abhishek Jha Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Abhishek Jha in
Google Scholar
PubMed
Close
, and
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed
Close

. 2008 , Taieb et al. 2009 ). SDHx -related metastatic PPGL typically exhibit a strong positivity in 18 F-FDG and SSTR PET, and a very limited uptake with specific tracers such as 18 F-FDOPA and 123 I-MIBG. This illustrates that the choice of

Free access
Arthur S Tischler Department of Pathology and Laboratory Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA

Search for other papers by Arthur S Tischler in
Google Scholar
PubMed
Close
and
Judith Favier Université Paris cité, Inserm UMR970 PARCC, Equipe Labellisée par la Ligue contre le cancer, Paris, France

Search for other papers by Judith Favier in
Google Scholar
PubMed
Close

SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomas . Cell Reports 38 110453. ( https://doi.org/10.1016/j.celrep.2022.110453 ) Barthez PY Marks SL Woo J Feldman EC

Free access
Jared S Rosenblum Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States

Search for other papers by Jared S Rosenblum in
Google Scholar
PubMed
Close
,
Herui Wang Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States

Search for other papers by Herui Wang in
Google Scholar
PubMed
Close
,
Matthew A Nazari Eunice Kennedy Shriver National Institute of Child Health and Development, Bethesda, Maryland, United States

Search for other papers by Matthew A Nazari in
Google Scholar
PubMed
Close
,
Zhengping Zhuang Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States

Search for other papers by Zhengping Zhuang in
Google Scholar
PubMed
Close
, and
Karel Pacak Eunice Kennedy Shriver National Institute of Child Health and Development, Bethesda, Maryland, United States

Search for other papers by Karel Pacak in
Google Scholar
PubMed
Close

the time, defects in genes putatively related to hypoxia signaling pathways such as VHL (von Hippel–Lindau), EGLN1 , and SDHx (succinate dehydrogenase complex genes) had been associated with neural crest tumors prior to our discovery ( Neumann

Free access